Cargando…
Prevention and treatment of COVID-19 in patients with benign and malignant blood disorders
Patients with moderate to severe immunosuppression, a condition that is common in many hematologic diseases because of the pathology itself or its treatment, are at high risk for COVID-19 and its complications. While empirical data are sometimes conflicting, this heightened risk has been confirmed i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398935/ https://www.ncbi.nlm.nih.gov/pubmed/36494144 http://dx.doi.org/10.1016/j.beha.2022.101375 |